145 related articles for article (PubMed ID: 38898561)
1. Pharmacogenetic testing in primary care could bolster depression treatment: A value proposition.
Sperber NR; Roberts MC; Gonzales S; Bendz LM; Cragun D; Haga SB; Wu RR; Omeogu C; Kaufman B; Petry NJ; Ramsey LB; Uber R
Clin Transl Sci; 2024 Jun; 17(6):e13837. PubMed ID: 38898561
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of a Pharmacogenetic Test to Guide Treatment for Major Depressive Disorder.
Groessl EJ; Tally SR; Hillery N; Maciel A; Garces JA
J Manag Care Spec Pharm; 2018 Aug; 24(8):726-734. PubMed ID: 30058980
[TBL] [Abstract][Full Text] [Related]
3. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. High Probability of Gene-Drug Interactions Associated with Medication Side Effects in Adolescent Depression: Results from a Randomized Controlled Trial of Pharmacogenetic Testing.
Nooraeen S; Croarkin PE; Geske JR; Shekunov J; Orth SS; Romanowicz M; Frye MA; Vande Voort JL
J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):28-33. PubMed ID: 38377526
[No Abstract] [Full Text] [Related]
6. Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness Studies.
Rosenblat JD; Lee Y; McIntyre RS
J Clin Psychiatry; 2017 Jun; 78(6):720-729. PubMed ID: 28068459
[TBL] [Abstract][Full Text] [Related]
7. The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care.
Saya S; Chondros P; Abela A; Mihalopolous C; Chatterton ML; Gunn J; Chen TF; Polasek TM; Dettmann E; Brooks R; King M; Spencer L; Alphonse P; Milton S; Ramsay G; Siviour Z; Liew J; Ly P; Thoenig M; Seychell R; La Rocca F; Hesson LB; Mejias N; Sivertsen T; Galea MA; Bousman C; Emery J
Trials; 2023 May; 24(1):342. PubMed ID: 37208772
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.
Bousman CA; Arandjelovic K; Mancuso SG; Eyre HA; Dunlop BW
Pharmacogenomics; 2019 Jan; 20(1):37-47. PubMed ID: 30520364
[TBL] [Abstract][Full Text] [Related]
9. Providers' Use of Pharmacogenetic Testing to Inform Antidepressant Prescribing: Results of Qualitative Interviews.
Vest BM; Wray LO; Thase ME; Brady LA; Chapman SR; Oslin DW
Psychiatr Serv; 2023 Dec; 74(12):1270-1276. PubMed ID: 37528698
[TBL] [Abstract][Full Text] [Related]
10. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial.
Oslin DW; Lynch KG; Shih MC; Ingram EP; Wray LO; Chapman SR; Kranzler HR; Gelernter J; Pyne JM; Stone A; DuVall SL; Lehmann LS; Thase ME; ; Aslam M; Batki SL; Bjork JM; Blow FC; Brenner LA; Chen P; Desai S; Dieperink EW; Fears SC; Fuller MA; Goodman CS; Graham DP; Haas GL; Hamner MB; Helstrom AW; Hurley RA; Icardi MS; Jurjus GJ; Kilbourne AM; Kreyenbuhl J; Lache DJ; Lieske SP; Lynch JA; Meyer LJ; Montalvo C; Muralidhar S; Ostacher MJ; Paschall GY; Pfeiffer PN; Prieto S; Przygodzki RM; Ranganathan M; Rodriguez-Suarez MM; Roggenkamp H; Schichman SA; Schneeweis JS; Simonetti JA; Steinhauer SR; Suppes T; Umbert MA; Vassy JL; Voora D; Wiechers IR; Wood AE
JAMA; 2022 Jul; 328(2):151-161. PubMed ID: 35819423
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of pharmacogenomic-guided treatment for major depression.
Ghanbarian S; Wong GWK; Bunka M; Edwards L; Cressman S; Conte T; Price M; Schuetz C; Riches L; Landry G; Erickson D; McGrail K; Peterson S; Vijh R; Hoens AM; Austin J; Bryan S
CMAJ; 2023 Nov; 195(44):E1499-E1508. PubMed ID: 37963621
[TBL] [Abstract][Full Text] [Related]
12. Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial.
Stäuble CK; Lampert ML; Allemann S; Hatzinger M; Hersberger KE; Meyer Zu Schwabedissen HE; Imboden C; Mikoteit T
Trials; 2021 Dec; 22(1):919. PubMed ID: 34906208
[TBL] [Abstract][Full Text] [Related]
13. Primary care and mental health providers' perceptions of implementation of pharmacogenetics testing for depression prescribing.
Vest BM; Wray LO; Brady LA; Thase ME; Beehler GP; Chapman SR; Hull LE; Oslin DW
BMC Psychiatry; 2020 Oct; 20(1):518. PubMed ID: 33115428
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial.
Pérez V; Salavert A; Espadaler J; Tuson M; Saiz-Ruiz J; Sáez-Navarro C; Bobes J; Baca-García E; Vieta E; Olivares JM; Rodriguez-Jimenez R; Villagrán JM; Gascón J; Cañete-Crespillo J; Solé M; Saiz PA; Ibáñez Á; de Diego-Adeliño J; ; Menchón JM
BMC Psychiatry; 2017 Jul; 17(1):250. PubMed ID: 28705252
[TBL] [Abstract][Full Text] [Related]
15. Economic Value of Pharmacogenetic Testing for Cancer Drugs with Clinically Relevant Drug-Gene Associations: A Systematic Literature Review.
Faruque F; Noh H; Hussain A; Neuberger E; Onukwugha E
J Manag Care Spec Pharm; 2019 Feb; 25(2):260-271. PubMed ID: 30698084
[TBL] [Abstract][Full Text] [Related]
16. Clinical Implementation of Pharmacogenetic Decision Support Tools for Antidepressant Drug Prescribing.
Zeier Z; Carpenter LL; Kalin NH; Rodriguez CI; McDonald WM; Widge AS; Nemeroff CB
Am J Psychiatry; 2018 Sep; 175(9):873-886. PubMed ID: 29690793
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study.
Perlis RH; Mehta R; Edwards AM; Tiwari A; Imbens GW
Depress Anxiety; 2018 Oct; 35(10):946-952. PubMed ID: 29734486
[TBL] [Abstract][Full Text] [Related]
18. Study design and implementation of the PRecision Medicine In MEntal health Care (PRIME Care) Trial.
Oslin DW; Chapman S; Duvall SL; Gelernter J; Ingram EP; Kranzler HR; Lehmann LS; Lynch JA; Lynch KG; Pyne JM; Shih MC; Stone A; Thase ME; Wray LO
Contemp Clin Trials; 2021 Feb; 101():106247. PubMed ID: 33316457
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic profile and major depressive and/or bipolar disorder treatment: a retrospective, cross-sectional study.
Tonozzi TR; Braunstein GD; Kammesheidt A; Curran C; Golshan S; Kelsoe J
Pharmacogenomics; 2018 Oct; 19(15):1169-1179. PubMed ID: 30207201
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
